Suppr超能文献

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions.

作者信息

Gonzalez-Cuevas Gustavo, Garcia-Gutierrez Maria S, Navarrete Francisco, de Guglielmo Giordano, Manzanares Jorge

机构信息

Department of Clinical Psychopharmacology, College of Pharmacy, Idaho State University, Meridian, ID, United States.

Instituto de Neurociencias Universidad Miguel Hernandez-CSIC, San Juan de Alicante, Spain.

出版信息

Front Pharmacol. 2021 Oct 18;12:752292. doi: 10.3389/fphar.2021.752292. eCollection 2021.

Abstract
摘要

相似文献

1
Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions.
Front Pharmacol. 2021 Oct 18;12:752292. doi: 10.3389/fphar.2021.752292. eCollection 2021.
2
Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II.
Front Pharmacol. 2023 Feb 23;14:1163991. doi: 10.3389/fphar.2023.1163991. eCollection 2023.
3
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28.
4
Cannabidiol, neuroprotection and neuropsychiatric disorders.
Pharmacol Res. 2016 Oct;112:119-127. doi: 10.1016/j.phrs.2016.01.033. Epub 2016 Feb 1.
5
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment.
Life Sci. 2019 May 1;224:120-127. doi: 10.1016/j.lfs.2019.03.053. Epub 2019 Mar 22.
7
Cannabidiol in Anxiety and Sleep: A Large Case Series.
Perm J. 2019;23:18-041. doi: 10.7812/TPP/18-041.
9
Cannabidiol effects on prepulse inhibition in nonhuman primates.
Rev Neurosci. 2018 Dec 19;30(1):95-105. doi: 10.1515/revneuro-2017-0101.
10
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
Neurosci Biobehav Rev. 2017 Jan;72:310-324. doi: 10.1016/j.neubiorev.2016.11.012. Epub 2016 Nov 22.

引用本文的文献

1
Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats.
Front Pharmacol. 2022 Jul 1;13:891842. doi: 10.3389/fphar.2022.891842. eCollection 2022.
2
Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective.
Transl Psychiatry. 2022 Jun 1;12(1):220. doi: 10.1038/s41398-022-01994-y.

本文引用的文献

1
Cannabidiol: pharmacology and therapeutic targets.
Psychopharmacology (Berl). 2021 Jan;238(1):9-28. doi: 10.1007/s00213-020-05712-8. Epub 2020 Nov 21.
2
[Not Available].
Can J Psychiatry. 2020 Apr;65(4):213-227. doi: 10.1177/0706743719895195. Epub 2019 Dec 13.
4
Cannabidiol Adverse Effects and Toxicity.
Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901.
5
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.
Front Pharmacol. 2018 Nov 26;9:1365. doi: 10.3389/fphar.2018.01365. eCollection 2018.
7
Cannabidiol does not display drug abuse potential in mice behavior.
Acta Pharmacol Sin. 2019 Mar;40(3):358-364. doi: 10.1038/s41401-018-0032-8. Epub 2018 Jul 18.
8
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.
Neuropsychopharmacology. 2018 Sep;43(10):2036-2045. doi: 10.1038/s41386-018-0050-8. Epub 2018 Mar 22.
10
Cannabidiol reduces ethanol consumption, motivation and relapse in mice.
Addict Biol. 2018 Jan;23(1):154-164. doi: 10.1111/adb.12495. Epub 2017 Feb 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验